龙血素B衍生物的合成及生物活性研究进展
Advances in Synthesis and Biological Activity of Loureirin B Derivatives
DOI: 10.12677/JOCR.2019.72008, PDF,    国家自然科学基金支持
作者: 林俊洁, 潘小霞*, 刘花, 李正英, 黄超*:云南民族大学化学与环境学院,云南 昆明
关键词: 龙血素B二氢查尔酮羟醛缩合生物活性Loureirin B Dihydrochalcone Aldol Condensation Biological Activity
摘要: 龙血素B是传统名贵中药材龙血竭的主要成分之一,也是龙血竭制剂国家药品标准中规定的指标性成分的标准对照物质。基于龙血素B的应用前景,本文综述了龙血素B衍生物的合成方法,利用简单的芳香醛和芳香酮通过羟醛缩合得到结构多样性的查尔酮类化合物,再将其还原得到二氢查尔酮。同时还整理了龙血素B具有镇痛、活血化瘀、消肿止痛、敛疮生肌等生物活性。希望通过本文能为后续龙血素B的研究提供参考。
Abstract: Loureirin B is one of the main ingredients of Dragon’s Blood, which is one of the most valuable traditional Chinese medicines. It is also the standard reference substance of the index ingredients stipulated in the national drug standard of Dragon’s Blood preparation. Based on the application prospects of Loureirin B, the synthesis methods of Loureirin B derivatives were reviewed. Chalcones with various structures were synthesized by aldol condensation of simple aromatic aldehydes and ketones, and then dihydrochalcones were reduced. At the same time, the biological activities of Loureirin B, such as analgesia, activating blood circulation and removing blood stasis, detumescence, pain relief, sore and muscle regeneration, were also sorted out. It is hoped that this paper can provide reference for the follow-up study of Loureirin B.
文章引用:林俊洁, 潘小霞, 刘花, 李正英, 黄超. 龙血素B衍生物的合成及生物活性研究进展[J]. 有机化学研究, 2019, 7(2): 54-62. https://doi.org/10.12677/JOCR.2019.72008

参考文献

[1] 国家药品监督管理局. .国家食品药品监督管理局药品标准[S]. WS3-B-2541-2001.
[2] 国家药典委员会, 编. 中华人民共和国药典[M]. 北京: 化学工业出版社, 2005: 96.
[3] 黄超, 王兴红, 刘接卿, 唐燕琼, 等. 龙血竭研究与开发[M]. 北京: 科学出版社, 2018.
[4] 上海大学. 4’-羟基-2, 4, 6-三甲氧基二氢查尔酮的制备方法[P]. 中国专利, CN101200410A. 2008.
[5] Sazegar, M.R., Mahmoudian, S., Mahmoudi, A., Triwahyono, S., Jalil, A.A., Mukti, R.R., Nazirah Kamarudin, N.H. and Ghoreishi, M.K. (2016) Catalyzed Claisen-Schmidt Reaction by Protonated Aluminate Mesoporous Silica Nanomaterial Focused on the (E)-Chalcone Synthesis as a Biologically Active Compound. RSC Advances, 6, 11023-11031. [Google Scholar] [CrossRef
[6] Khan, K. and Siddiqui, Z.N. (2014) Piperidine-Functionalized Silica: An Efficient and Environmentally Benign Catalyst for Claisen-Schmidt Condensation. Applied Organometallic Chemistry, 28, 789-796.
[7] 王晓晶, 杨淬, 王兴红, 黄超. 剑叶龙血素A衍生物的合成及其镇痛活性研究[J]. 云南大学学报(自然科学版), 2018, 40(4): 748-754.
[8] 陆文兴, 沿朝国, 顾惠芬. 查尔酮KF-Al2O3催化合成[J]. 化学试剂, 1995, 17(4): 253-254
[9] 蒋新宇, 赵爱丽. 聚乙二醇相转移催化法合成查耳酮[J]. 广州化学, 2006, 31(3): 1-5+10.
[10] 关丽萍, 尹秀萍, 全红梅, 等. 羟基查尔酮类衍生物的合成[J]. 有机化学, 2004, 24(10): 1274-1277.
[11] Narender, T. and Papi Reddy, K. (2007) A Simple and Highly Efficient Method for the Synthesis of Chalcones by Using Borontrifluoride-Etherate. Tetrahedron Letters, 48, 3177-3180. [Google Scholar] [CrossRef
[12] 曾波涛, 赵志刚. 易奉敏, 等. 微波促进无溶剂合成查尔酮衍生物[J]. 合成化学, 2007, 15(5): 625-627.
[13] 吴浩, 叶红齐, 陈东初. 绿色合成查尔酮新方法的研究[J]. 工业催化, 2006, 14(6): 34-37.
[14] Zhao, X.-L., Li, H.-Z. and Da, S.-J. (2011) A Concise Synthetica Approach to Dihydro-chalcone: First Totol Syntheses of Bipinnatone A and B. Chinese Chemistry Letters, 22, 1135-1138.
[15] 张永霞. α, β-不饱和羰基化合物的碳碳双键选择性还原研究[D]: [硕士学位论文]. 新乡: 河南师范大学, 2005.
[16] Hermoso, A., Jiménez, I.A., Mamani, Z.A., Bazzocchi, I.L., Piñero, J.E., Ravelo, A.G. and Valladares, B. (2003) Antileishmanial Activities of Dihydrochalcones from piper elongatum and Synthetic Related Compounds. Structural Requirements for Activity. Bioorganic & Medicinal Chemistry, 11, 3975-3980. [Google Scholar] [CrossRef
[17] 刘向明, 陈素, 尹世金, 梅之南. 血竭及其成分龙血素B对背根神经节细胞河豚毒素敏感型钠通道电流的影响[J]. 中国科学C辑, 2004, 34(1): 80-87.
[18] Wang, S.-T., Chen, S., Guo, M. and Liu, X.-M. (2008) Inhibitory Effect of Cochinchinenin B on Capsaicin-Activated Responses in Rat Dorsal Root Ganglion Neurons. Brain Research, 1201, 34-40. [Google Scholar] [CrossRef] [PubMed]
[19] 陈玉立, 陈素, 刘向明. 龙血竭镇痛和阻滞神经传导作用的实验研究[J]. 时珍国医国药, 2010, 21(10): 2446-2447.
[20] 张凡, 马全顺, 陈素, 尹世金, 刘向明. 龙血素B对三叉神经节河豚毒素不敏感型钠通道电流的调制作用[J]. 时珍国医国药, 2006, 17(6): 947-949.
[21] 马鹏飞, 潘鑫鑫, 万莹, 陈素. 龙血素B对牛蛙坐骨神经干兴奋传导的影响[J]. 绿色科技, 2017(10): 215-217.
[22] 王灿, 陈素, 刘向明. 龙血素B抑制大鼠背根神经节细胞辣椒素诱发的电流反应[J]. 中国药理学通报, 2007, 23(2): 211-214.
[23] 郭敏, 陈素, 刘向明. 龙血竭抑制大鼠脊髓背角广动力范围神经元诱发放电的药效物质[J]. 中国科学C辑, 2008, 38(12): 1130-1142.
[24] 陈素, 刘向明. 血竭及其成分龙血素B影响背根神经节细胞钠离子通道的计算机模拟研究[J]. 生物医学工程学杂志, 2006, 23(6): 1172-1176.
[25] 闫冬. 中药龙血竭和毛两面针的抗血栓抗纤维化新机制研究[D]: [硕士学位论文]. 大连: 辽宁师范大学, 2016.
[26] 闫冬. 龙血素B对纤溶酶原激活物抑制剂的抑制作用[J]. 生物化工, 2016, 2(2): 49-50.
[27] 邓家刚, 黄海滨, 农毅清, 刘园. 龙血素B的药效学实验研究[J]. 广西中医药, 2004, 27(1): 44-46.
[28] 张天宝, 吕敬慈, 雍克岚, 徐鲁荣, 陈旭. 广西龙血竭中几种化学成分对血小板聚集影响的初步研究[J]. 天然产物研究与开发, 2008, 20(4): 695-697.
[29] 程敏. 不同产地血竭在血液和心血管方面药效学比较及作用机制初探[D]: [硕士学位论文]. 广州: 广东药学院, 2007.
[30] He, T., Bai, X., Yang, L., Fan, L., Li, Y., Su, L., Gao, J., Han, S. and Hu, D. (2015) Loureirin B Inhibits Hypertrophic Scar Formation via Inhibition of the TGF-β1-ERK/JNK Pathway. Cellular Physiology and Biochemistry, 37, 666-676. [Google Scholar] [CrossRef] [PubMed]
[31] Bai, X., He, T., Liu, J., Wang, Y., Fan, L., Tao, K., Shi, J., Tang, C., Su, L. and Hu, D. (2015) Loureirin B Inhibits Fibroblast Proliferation and Extracellular Matrix Deposition in Hypertrophic Scar via TGF-β/Smad Pathway. Experimental Dermatology, 24, 355-360. [Google Scholar] [CrossRef] [PubMed]
[32] Ichikawa, K., Kitaoka, M., Taki, M., Takaishi, S., Boriboon, M., Iijima, Y. and Akiyama, T. (1997) Retrodihydrochalcones and Homoisoflavones Isolated from Thai Medicinal Plant Dracaena loureiri and Their Estrogen Agonist Activity. Planta Medica, 63, 540-543. [Google Scholar] [CrossRef] [PubMed]
[33] 彭伟, 范红, 宋正己, 陶健. 龙血素B对肝纤维化大鼠肝细胞氧化应激损伤干预作用的研究[J]. 中国实用内科杂志, 2009, 29(S2): 87-89.
[34] 李玉莲, 范红, 宋正己, 彭伟, 陈艳敏, 高建梅. 龙血素B对肝星状细胞增殖及细胞外基质分泌的影响[J]. 山东医药, 2012, 52(13): 7-9.